Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Keith Crandell - aVenture Research

Keith Crandell

AddedMar 31, 2024

UpdatedOct 12, 2026

Keith Crandell

Keith Crandell

Co-Founder, Arch Venture Partners

Keith Crandell's Career

Arch Venture Partners

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Investment FirmChicago, IL, US

Co-Founder

908 Devices

Public$66.8MBoston, MA, US

Board Member· Board

Twist Bioscience

Public$553.1MSan Francisco, CA, US

Board Member· Board

Pixelexx Systems

$2.2MChicago, IL, US

Board Member· Board

Permeon Biologics

Seed$2.5MCambridge, MA, US

Board Member· Board

Ciespace

Series B$6MSanta Clara, CA, US

Board Member· Board

Cytrellis Biosystems

Series C$86.1MWoburn, MA, US

Board Member· Board

Ultivue

Series D$107.3MCambridge, MA, US

Board Member· Board

Arbor Biotechnologies

Series B$230.6MCambridge, MA, US

Board Member· Board

Nanosys

$246.7MMilpitas, CA, US

Board Member· Board

National Venture Capital Association

Non-ProfitWashington, D.C., DC, US

Director

People Similar to Keith Crandell

Kevin McCallionCo-Founder · 908 Devices

Kevin HrusovskyBoard Member · Quanterix

Chad WaiteBoard Member · National Venture Capital Association

Steve AraizaCo-Founder · 908 Devices

Feng DengBoard Member · Tsinghua Holdings

Scott MillerCo-Founder · 908 Devices

Recent news

Oratomic raises $475M for neutral-atom quantum computing, Universal Quantum nets $100M+SiliconANGLE · 2026

Exclusive | Quantum Startup Oratomic Now Worth $5.4 Billion After Series-B FundingWall Street Journal · 2026

Oratomic raises $300M to build a viable quantum computer that needs only 20K qubitsTechCrunch · 2026

Leadership at Arch Venture Partners

Robert NelsenCo-Founder

Clinton BybeeCo-Founder

Steve LazarusCo-Founder

Similar to Arch Venture Partners

Atlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29

Leadership at 908 Devices

J. Michael RamseyCo-Founder

Andy BartfayCo-Founder

Fenel EloiBoard Member

Nicolas BarthelemyBoard Member

Christopher PettyCo-Founder

Mark SpotoBoard Member

Similar to 908 Devices

RedShift BioAnalyticsBurlington, MA, USBioanalytical Instrumentsest. 2005RedShift BioAnalyticsBurlington, MA, US · est. 2005

RedShift BioAnalytics: Global manufacturer of bioanalytical instruments for protein-based drug development.

Series E · $65.7M33

Leadership at Twist Bioscience

Bill BanyaiBoard Member

Bob RagusaBoard Member

Emily LeproustBoard Member

Rob ChessBoard Member

Xiaoying MaiBoard Member

Melissa StarovasnikBoard Member

Similar to Twist Bioscience

Ultima GenomicsFremont, CA, USGenomic Sequencingest. 2016Ultima GenomicsFremont, CA, US · est. 2016

Ultima Genomics develops high-throughput DNA sequencing systems, library preparation workflows, and analysis tools.

Leadership at Pixelexx Systems

Stuart SolinFounder

Similar to Pixelexx Systems

Vita ImagingFremont, CA, USMedical Devicesest. 2019Vita ImagingFremont, CA, US · est. 2019

Vita Imaging, a Fremont-based manufacturer, develops advanced medical devices for accurate, rapid cancer detection.

NanoMedTrixCoralville, IA, USCancer Treatment, Nanoparticlesest. 2012NanoMedTrixCoralville, IA, US · est. 2012

NanoMedTrix: Pioneering nanoparticle tech for biomedical imaging and targeted cancer treatment since 2012.

O2M TechnologiesChicago, IL, USMedical Devicesest. 2017O2M TechnologiesChicago, IL, US · est. 2017

O2M Technologies, founded in 2017, develops oxygen imaging devices for cancer and regenerative medicine.

Angel · $1.2M6

Diagnostic PhotonicsChicago, IL, USImaging, Medical Devicesest. 2008Diagnostic PhotonicsChicago, IL, US · est. 2008

Chicago-based Diagnostic Photonics creates real-time, advanced imaging tech for tissue evaluation.

Series B · $3M30

Leadership at Permeon Biologics

Patrick GageBoard Member

Katherine BowdishBoard Member

John EdwardsBoard Member

Similar to Permeon Biologics

Purinomia BiotechWoburn, MA, USBiologicals, Drug Developmentest. 2017Purinomia BiotechWoburn, MA, US · est. 2017

Purinomia Biotech: MA-based innovator in biologicals and drug development for diverse diseases.

Rekindle TherapeuticsCambridge, MA, USMedical Solutionsest. 2018Rekindle TherapeuticsCambridge, MA, US · est. 2018

Cambridge-based biotech, Rekindle Therapeutics, innovating in medical solutions.

Pre-Seed · $1.1M5

ProFound TherapeuticsCambridge, MA, USTherapeuticsest. 2022ProFound TherapeuticsCambridge, MA, US · est. 2022

ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.

Series A · $75M35

Solarea BioCambridge, MA, USBiotechnology, Therapeuticsest. 2017Solarea BioCambridge, MA, US · est. 2017

Solarea Bio, a Cambridge-based biotech firm, innovates microbiome solutions for global health issues.

Series B · $26.2M24

Leadership at Ciespace

Kenji ShimadaFounder

Thomas CurryBoard Member

Similar to Ciespace

CogniticsBoise, ID, USProgramming, Softwareest. 2008CogniticsBoise, ID, US · est. 2008

Cognitics, Inc.: Expert software product developer and computer programming services since 2008.

Seed · $7.5k12

BytespacePalo Alto, CA, USSoftwareest. 2022BytespacePalo Alto, CA, US · est. 2022

Bytespace, founded in 2022, is a Palo Alto-based software company.

Citius SoftwareLakeway, TX, USSoftwareest. 2009Citius SoftwareLakeway, TX, US · est. 2009

Lakeway-based software company providing solutions for Government and Service Industry.

Angel · $250k30

CE InteractiveNew York City, NY, USServices, Softwareest. 2004CE InteractiveNew York City, NY, US · est. 2004

US-based CE Interactive Inc. provides comprehensive software services and solutions.

Series A · $2.4M8

Leadership at Cytrellis Biosystems

Doug LevinsonFounder

John McDonoughBoard Member

Frederick BeddingfieldBoard Member

Michael PetersonBoard Member

Amit MunshiBoard Member

R Jason RicheyCEO

Similar to Cytrellis Biosystems

Syntr Health TechnologiesIrvine, CA, USMedical Devicesest. 2016Syntr Health TechnologiesIrvine, CA, US · est. 2016

Syntr Health Technologies: Innovating body contouring devices, founded by biomedical experts.

Series A · $2.2M8

Leadership at Ultivue

Fenel EloiBoard Member

Ralf JungmannCo-Founder

David WaltCo-Founder

Peng YinCo-Founder

Adam WieschhausBoard Member

Martin MadausBoard Member

Similar to Ultivue

SpIntellxPittsburgh, PA, USAnalytics, Softwareest. 2017SpIntellxPittsburgh, PA, US · est. 2017

SpIntellx develops AI-powered software for personalized medicine, using spatial analytics on pathology samples.

Leadership at Arbor Biotechnologies

Paul MeisterBoard Member

Chen YuBoard Member

Feng ZhangCo-Founder

Winston YanCo-Founder

David ScottCo-Founder

Similar to Arbor Biotechnologies

MetagenomiEmeryville, CA, USGene Editingest. 2016MetagenomiEmeryville, CA, US · est. 2016

Metagenomi: Pioneering next-gen gene-editing systems to treat genetic diseases.

Public · $457M191

Recent news

Shoei Chemical Acquires Quantum Dot Business from NanosysNanosys · 2023

Nanosys Announces Martin Devenney as New CEONanosys · 2023

2023 is the Year of the Quantum Dot with several major milestones for Nanosys Quantum Dot technology in the Display MarketNanosys · 2023

Leadership at Nanosys

Jason HartloveBoard Member

Steve OesterleBoard Member

Bruce BerkoffBoard Member

Greg YurekBoard Member

Narbeh DerhacobianBoard Member

Steve GoldbyBoard Member

Similar to Nanosys

QNA TechnologyQNA Technology

QNA Technology develops heavy-metal-free colloidal quantum dots, including blue emitters, for displays and lighting.

UbiQDLos Alamos, NM, USAdvanced Materials, Research And Developmentest. 2014UbiQDLos Alamos, NM, US · est. 2014

Ubiqd Inc, founded in 2014 in Los Alamos, US, specializes in commercial physical and biological R&D.

Leadership at National Venture Capital Association

Deena ShakirBoard Director

Timothy CurtBoard Member

Jan GarfinkleBoard Member

Nick WashburnBoard Member

Vic ParkerBoard Member

Rob KettersonBoard Member

Similar to National Venture Capital Association

Angel Capital AssociationOverland Park, KS, USProfessional Developmentest. 2005Angel Capital AssociationOverland Park, KS, US · est. 2005

Leading association providing resources, advocacy, and professional development for angel investors.

Arch Development PartnersChicago, IL, USest. 2001

Arch Development PartnersChicago, IL, US · est. 2001

ARCH Development Partners, L.L.C. is a US-based venture capital firm serving various clients.

Investment Firm30

Archer Venture CapitalLos Angeles, CA, USest. 2010Archer Venture CapitalLos Angeles, CA, US · est. 2010

Archer Venture Capital: An investment and advisory firm for start-ups and entrepreneurs.

Investment Firm8

Archina Capital PartnersRhode Island, USest. 2015Archina Capital PartnersRhode Island, US · est. 2015

ARCHina Capital: Funding next-gen companies with global potential through venture capital.

Investment Firm5

ExPrimaryRockville, MD, USMedical Devicesest. 2013

ExPrimaryRockville, MD, US · est. 2013

ExPrimary, a biotech firm, innovates medical devices for cell analysis, advancing personalized healthcare since 2013.

Pre-Seed · $100k6

Beta BionicsIrvine, CA, USMedical Devicesest. 2015Beta BionicsIrvine, CA, US · est. 2015

Biotech firm, Beta Bionics, innovates bionic pancreas systems for improved diabetes care in the US.

Public · $293.5M160

NanostreamPasadena, CA, USAnalysis Equipment, Biotechnology Toolsest. 1999NanostreamPasadena, CA, US · est. 1999

Nanostream Inc.: US-based provider of biotechnology tools and analysis equipment.

Series C · $22M50

Switchback SystemsSan Francisco, CA, USDNA Synthesisest. 2019

Switchback SystemsSan Francisco, CA, US · est. 2019

Switchback Systems, a San Francisco-based software startup, specializes in efficient, scalable DNA synthesis platforms.

Seed · $7.1M14

Ansa BiotechnologiesEmeryville, CA, USDNA Synthesisest. 2018Ansa BiotechnologiesEmeryville, CA, US · est. 2018

Ansa Biotechnologies: Pioneering enzyme-based, efficient DNA synthesis.

Series B · $128.4M82

SynthexSan Francisco, CA, USConsulting, Drug Discoveryest. 2016SynthexSan Francisco, CA, US · est. 2016

SyntheX: Pioneering next-gen drug discovery platforms through synthetic biology and consulting services.

Series A · $11.6M11

Revelle AestheticsMountain View, CA, USMedical Devicesest. 2018

Revelle AestheticsMountain View, CA, US · est. 2018

Revelle Aesthetics: A passionate team innovating in the medical device and aesthetics industry.

Series C · $105M50

Sperry BioSpringfield, VT, USMedical Devicesest. 2019Sperry BioSpringfield, VT, US · est. 2019

Sperry Bio, a Vermont-based manufacturer, specializes in medical devices for regenerative skin medicine research.

Angel · $255.4k6

ClearItMarblehead, MA, USMedical Devicesest. 2013ClearItMarblehead, MA, US · est. 2013

ClearIt: A biotech firm specializing in healthcare and medical device manufacturing, known for its tattoo ERASER System.

Seed · $2.6M10

TenSixty BiosciencesCambridge, MA, USTherapeuticsest. 2021

TenSixty BiosciencesCambridge, MA, US · est. 2021

TenSixty BioSciences innovates small molecule therapeutics through high throughput experiments.

Series A · $7.2M50

NovasentaPittsburgh, PA, USCancer Treatmentsest. 2018NovasentaPittsburgh, PA, US · est. 2018

Novasenta: Innovating cancer treatment through rigorous tumor analysis and targeted therapies.

Series A · $40M36

PredxBioPittsburgh, PA, USDiagnostics, Precision Pathologyest. 2017PredxBioPittsburgh, PA, US · est. 2017

PredxBio: Advancing precision pathology with AI for optimized clinical trials and personalized therapy.

Seed · $1.1M13

Arpeggio BiosciencesBoulder, CO, USDrug Developmentest. 2018

Arpeggio BiosciencesBoulder, CO, US · est. 2018

Arpeggio Bio: AI-driven drug development targeting transcription factors for hard-to-treat diseases.

Series A · $20.4M18

Caribou BiosciencesBerkeley, CA, USMedical Therapiesest. 2011Caribou BiosciencesBerkeley, CA, US · est. 2011

Caribou Biosciences: A global provider of medical therapies and bio-based products based in Berkeley, US.

Public · $317.7M137

Acrigen BiosciencesAlameda, CA, USGene Editingest. 2019Acrigen BiosciencesAlameda, CA, US · est. 2019

Acrigen Biosciences: Precision gene-editing tech firm developing therapies for genetic disorders.

Seed · $1.2M11

Public · $20.7M

23

AvantamaAvantama

Avantama develops nanoparticle and quantum dot formulations for displays, lighting, and electronics.

Quantum MaterialsSan Marcos, TX, USQuantum Dots, Solar Cellsest. 2007Quantum MaterialsSan Marcos, TX, US · est. 2007

Quantum Materials Corp. designs and supplies nanotech quantum dots and manufactures solar cells globally.

Public · $15.5M23

VentureWellHadley, MA, USTrainingest. 1995

VentureWellHadley, MA, US · est. 1995

VentureWell: Funding, training, and catalyzing student-led ventures for social and environmental impact.

Nonprofit143

Venture for AmericaNew York City, NY, USest. 2011Venture for AmericaNew York City, NY, US · est. 2011

Venture for America: A non-profit fostering economic growth in US cities through entrepreneurship training.

Activation CapitalRichmond, VA, USInnovation Programsest. 1993Activation CapitalRichmond, VA, US · est. 1993

Empowering innovation and talent in Richmond's ecosystem.